Stay updated on IPI-145 Plus FCR in CLL Clinical Trial
Sign up to get notified when there's something new on the IPI-145 Plus FCR in CLL Clinical Trial page.

Latest updates to the IPI-145 Plus FCR in CLL Clinical Trial page
- Check4 days agoChange DetectedAdded the term 'B-cell chronic lymphocytic leukemia' and a 'Genetic and Rare Diseases Information Center' resource to the study page.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. No visible content or feature changes are indicated.SummaryDifference0.1%

- Check26 days agoChange DetectedThe page revision was updated to v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

- Check48 days agoChange DetectedUpdates shown (2026-01, 2026-01-27, 2026-02-13) appear to be administrative metadata changes to the study record, such as new update timestamps, and do not modify core content like eligibility criteria, endpoints, or interventions. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check55 days agoChange DetectedRevision: v3.4.2 was added and Revision: v3.4.1 was removed, along with deletion of the funding-status notice, with no changes to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedA site-wide Notice about government funding and NIH Clinical Center operations was added, and the revision tag was updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

Stay in the know with updates to IPI-145 Plus FCR in CLL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IPI-145 Plus FCR in CLL Clinical Trial page.